WHO ICTRP trial
HYPER-trial Hyperemic mYocardial Perfusion by adEnosine at diffeRent doses
CTIS2023-505248-20-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2023-505248-20-00 |
|---|---|
| Public title | HYPER-trial Hyperemic mYocardial Perfusion by adEnosine at diffeRent doses |
| Scientific title | HYPER-trial Hyperemic mYocardial Perfusion by adEnosine at diffeRent doses |
| Primary sponsor | Region Skane |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): Yes |
| Countries | Sweden |
| Conditions | Chronic coronary syndrome MedDRA version: 20.0Level: LLTClassification code: 10008937Term: Chronic ischemic heart disease unspecified Class: 10007541 MedDRA version: 20.0Level: LLTClassification code: 10055218Term: Ischemic heart disease… |
| Interventions | Product Name: Clariscan 0,5 mmol/ ml injektionsvätska, lösning, Product Code:PRD4802273, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength: , Product Name: Adenosin Life Medical 5 mg/ml… |
| Registration date | Nov 29, 2023 |
| Target size | 180 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: